Library / Laws / 117th Congress / House Bills / H.R. 7529
H.R. 7529
To require direct-to-consumer advertisements for prescription drugs and biological products to include truthful and not misleading pricing information.
| Print stage | Date | Size | ⠃ |
|---|---|---|---|
| Introduced in House | 2022-04-14 | 2.0K | ⠃⠗⠋ |